Homa Hemati

6PUBLICATIONS
16CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 29, 2025
Shared Decision Making Interventions for Deprescribing in Older Adults With Polypharmacy: A Scoping Review.

Soroush Fariman, Arman Arabshomali, Darshna Goordeen

|May 14, 2025
Cost-Utility Analysis of Trastuzumab-Emtansine Versus Trastuzumab for the Treatment of Residual Invasive HER-2-Positive Breast Cancer in Iran.

Homa Hemati, Marzieh Nosrati, Meysam Seyedifar

|Nov 27, 2024
Correction: Azari et al. The Efficacy of Ketamine for Acute and Chronic Pain in Patients with Cancer: A Systematic Review of Randomized Controlled Trials. Healthcare 2024, 12, 1560.

Leila Azari, Homa Hemati, Ronia Tavasolian

|Aug 29, 2024
The Efficacy of Ketamine for Acute and Chronic Pain in Patients with Cancer: A Systematic Review of Randomized Controlled Trials.

Leila Azari, Homa Hemati, Ronia Tavasolian

|Aug 07, 2024
Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve.

Homa Hemati, Marzieh Nosrati, Mandana Hasanzad

|Jul 22, 2024
Assessing the Validity of the Centers for Medicare & Medicaid Services Measure in Identifying Potentially Preventable Emergency Department Visits by Patients With Cancer.

Amir Alishahi Tabriz, Kea Turner, Homa Hemati

Pageof 1

Frequent Collaborators

2 joint publications

Marzieh Nosrati

2 joint publications

Soroush Fariman

2 joint publications

Amir Alishahi Tabriz

2 joint publications

Heather S L Jim